CPNE4

Copine-4 · Q96A23 · CPNE4 on Sugi Atlas →

0 patent compounds predicted against CPNE4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CPNE4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
CP-EDIT: Cerebral Palsy - Early Diagnosis and Intervention Trial nanRECRUITING
Genetic Etiology in Patients With Cerebral Palsy nanCOMPLETED
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study nanCOMPLETED
Cuevas Medek Exercises on Balance and Postural Control in Children With Spastic Cerebral Palsy nanCOMPLETED
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) nanRECRUITING
Incidence of cCPHD in Denmark - a National Observational Study nanUNKNOWN
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Characteristics of Idiopathic Familial Voice Disorders nanCOMPLETED
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters nanUNKNOWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Swiss Cerebral Palsy Registry nanRECRUITING
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome nanACTIVE_NOT_RECRUITING
Mitochondrial Membrane Protein Neurodegeneration (MPAN) nanCOMPLETED
Genomic Analysis of Families With a History of Discordant Cancers nanRECRUITING
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Early Detection and Characterization of Primary Ciliary Dyskinesia nanUNKNOWN
Corpus Callosum Agenesis and Intellectual Disability nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Emotional Regulation in Children With ND: the Role of Genomic Variation, Proteomic Patterns, and Early Experience nanUNKNOWN
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 nanCOMPLETED
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CPNE4 binder may also engage these)

ProteinNameSimilarity
Q8BLR2 1.000 Q8BLR2 →
P59108 1.000 P59108 →
Q8IYJ1 0.995 Q8IYJ1 →
Q1RLL3 0.995 Q1RLL3 →
Q9HCH3 0.995 Q9HCH3 →
Q86YQ8 0.994 Q86YQ8 →
Q8JZW4 0.993 Q8JZW4 →
Q0VE82 0.993 Q0VE82 →
O75131 0.992 O75131 →
Q5RAE1 0.992 Q5RAE1 →
Q9DC53 0.992 Q9DC53 →
Q5BJS7 0.991 Q5BJS7 →
Q96FN4 0.989 Q96FN4 →
Q8BT60 0.988 Q8BT60 →
Q5R4W6 0.987 Q5R4W6 →
Q08DB4 0.983 Q08DB4 →
H1UBN0 0.982 H1UBN0 →
Q9Z140 0.982 Q9Z140 →
Q5XQC7 0.979 Q5XQC7 →
Q941L3 0.977 Q941L3 →
O95741 0.976 O95741 →
A8WMY4 0.975 A8WMY4 →
Q2KHY1 0.975 Q2KHY1 →
D4A1R8 0.974 D4A1R8 →
Q5S1W2 0.974 Q5S1W2 →
Q8C166 0.974 Q8C166 →
Q32NH8 0.974 Q32NH8 →
Q86K21 0.973 Q86K21 →
Q28479 0.973 Q28479 →
O42130 0.973 O42130 →